1. Home
  2. SPRO vs MOB Comparison

SPRO vs MOB Comparison

Compare SPRO & MOB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

SPRO

Spero Therapeutics Inc.

N/A

Current Price

$1.14

Market Cap

71.0M

Sector

Health Care

ML Signal

N/A

Logo Mobilicom Limited

MOB

Mobilicom Limited

N/A

Current Price

$4.60

Market Cap

73.7M

Sector

Real Estate

ML Signal

N/A

Company Overview

Basic Information
Metric
SPRO
MOB
Founded
2013
2008
Country
United States
Israel
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Real Estate Investment Trusts
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
71.0M
73.7M
IPO Year
2017
2021

Fundamental Metrics

Financial Performance
Metric
SPRO
MOB
Price
$1.14
$4.60
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$10.00
AVG Volume (30 Days)
355.5K
120.6K
Earning Date
05-13-2026
03-23-2026
Dividend Yield
N/A
N/A
EPS Growth
111.81
N/A
EPS
N/A
N/A
Revenue
$66,802,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$300.00
$150.10
P/E Ratio
N/A
N/A
Revenue Growth
39.24
N/A
52 Week Low
$1.08
$4.33
52 Week High
$3.08
$11.01

Technical Indicators

Market Signals
Indicator
SPRO
MOB
Relative Strength Index (RSI) 32.01 31.07
Support Level $1.13 N/A
Resistance Level $1.29 $5.67
Average True Range (ATR) 0.04 0.32
MACD 0.01 -0.12
Stochastic Oscillator 15.53 5.19

Price Performance

Historical Comparison
SPRO
MOB

About SPRO Spero Therapeutics Inc.

Spero Therapeutics Inc is a clinical-stage biopharmaceutical firm. It focuses on identifying, developing, and commercializing novel treatments for MDR (Multi-drug-resistant) bacterial infections and rare diseases. The company's product candidate, tebipenem pivoxil hydrobromide or tebipenem HBr, is designed to be an oral carbapenem-class antibiotic for use in adults to treat MDR Gram-negative infections. It is also developing SPR720, a novel oral antibiotic designed for the treatment of a rare, orphan disease caused by pulmonary non-tuberculous mycobacterial infections, or NTM disease. It is also focused on SPR206, a next-generation polymyxin investigational product candidate being developed as an IV-administered medicine to treat MDR Gram-negative infections in the hospital.

About MOB Mobilicom Limited

Mobilicom Ltd is a provider of cybersecurity and smart solutions for drones, robotics & autonomous platforms. As a high-tech company, it designs, develops, and delivers smart solutions targeting global drone, robotics, and autonomous system manufacturers. Its products include OS3 Platform Software, ICE Cybersecurity Software, MCU Mesh Networking, SkyHopper Datalinks, Mobile Ground Control Stations and System Engineering Services.

Share on Social Networks: